HRT and Alzheimer's Disease

JANUARY 01, 2003

The bad news is that hormone replacement therapy (HRT) may increase the likelihood of breast cancer in postmenopausal women. The good news, according to the results of a study published in the Journal of the American Medical Association (November 6, 2002), is that women who have taken HRT for at least 10 years are 2.5 times less likely to develop Alzheimer?s disease than non-HRT women.

The following are 2 other key points from this study: First, there was no benefit unless HRT had been begun several years before the onset of mental decline. Second, vitamin and calcium supplements had no effect on Alzheimer?s disease risk.



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.